FDA Inspection 773087 — Bracco Diagnostics, Inc.

Bracco Diagnostics, Inc. — FEI 1000307800

The FDA completed an inspection of Bracco Diagnostics, Inc. on March 8, 2012 in Princeton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 8, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
745321 CFR 312.56(b)Investigator non-compliance
745921 CFR 312.57(a)Records of receipt, shipment, disposition
748221 CFR 312.50General responsibilities of sponsors
755721 CFR 312.56(b)Notification of FDA of termination of investigator